Applying a Novel CD8 Treg Directed Therapeutic Approach to the Clinic
Time: 10:30 am
day: Day Two AM Non-Cell Based Approaches
Details:
- Discussing the significance of regulatory CD8 T cells in autoimmune disease
- Discussing the therapeutic potential of modulating CD8 Treg for the treatment of autoimmune disease
- Advancing the CD8 Treg modulator MTX-101 targeting inhibitory KIR as autoimmune checkpoint into the clinic for the treatment of autoimmune disease
